COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,833 Articles (22,553 medRxiv, 8,280 bioRxiv)

Most recent first Previous |  Page 2996: Articles 29951-29960  | Next

Design of potent membrane fusion inhibitors against SARS-CoV-2, an emerging coronavirus with high fusogenic activity
Zhu, Y., Yu, D., Yan, H., Chong, H., He, Y.
10.1101/2020.03.26.009233 — Posted: 2020-03-28
Mechanical Ventilator Milano (MVM):A Novel Mechanical Ventilator Designed for Mass Scale Production in response to the COVID-19 Pandemics
Cristiano, G., Bonivento, W., Caravati, M., Razeti, M., DeCecco, S., Fiorillo, G., Gabriele, F., Tartaglia, R., Razeto, A., Sablone, D., Scapparone, E., Testera, G., Rescigno, M., Franco, D., Kochanek, I., Kendziora, C., Pordes, S. H., Wang, H., Ianni, A., McDonald, A., Molinari Tosatti, L., Dinon, T., Malosio, M., Minuzzo, D., Zardoni, A., Prini, A.
10.1101/2020.03.24.20042234 — Posted: 2020-03-27
Serology characteristics of SARS-CoV-2 infection since the exposure and post symptoms onset
Lou, B., Li, T., Zheng, S., Su, Y., Li, Z., Liu, W., Yu, F., Ge, S., Zou, Q., Yuan, Q., Lin, S., Hong, C., Yao, X., Zhang, X., Wu, D., Zhou, G., Hou, W., Li, T., Zhang, Y., Zhang, S., Fan, J., Zhang, J., Xia, N., Chen, Y.
10.1101/2020.03.23.20041707 — Posted: 2020-03-27 Discussion: Onsite
UV Sterilization of Personal Protective Equipment with Idle Laboratory Biosafety Cabinets During the Covid-19 Pandemic
Theory Division, Cleveland Clinic Lerner Research Institute, , Card, K. J., Crozier, D., Dhawan, A., Dinh, M., Dolson, E., Farrokhian, N., Gopalakrishnan, V., Ho, E., King, E. S., Krishnan, N., Kuzmin, G., Maltas, J., Pelesko, J., Scarborough, J. A., Scott, J. G., Sedor, G., Weaver, D. T.
10.1101/2020.03.25.20043489 — Posted: 2020-03-27 Discussion: Onsite
Therapeutic Application of Chloroquine in Clinical Trials for COVID-19
Rana, D. R., Dulal, S.
10.1101/2020.03.22.20040964 — Posted: 2020-03-27
Impact of changing case definitions for COVID-19 on the epidemic curve and transmission parameters in mainland China
Tsang, T. K., Wu, P., Yun Lin, Y. L., Lau, E., Leung, G. M., Cowling, B. J.
10.1101/2020.03.23.20041319 — Posted: 2020-03-27
Modeling COVID-19 epidemics in an Excel spreadsheet: Democratizing the access to first-hand accurate predictions of epidemic outbreaks
Alvarez, M. M., Gonzalez-Gonzalez, E., Trujillo-de Santiago, G.
10.1101/2020.03.23.20041590 — Posted: 2020-03-27 Discussion: Onsite
COVID-19 attack rate increases with city size
Stier, A. J., Berman, M. G., Bettencourt, L. M. A.
10.1101/2020.03.22.20041004 — Posted: 2020-03-27 Discussion: Onsite | Offsite
Global transmission network of SARS-CoV-2: from outbreak to pandemic
Skums, P., Kirpich, A., Icer Baykal, P., Zelikovsky, A., Chowell, G.
10.1101/2020.03.22.20041145 — Posted: 2020-03-27
Modelling strategies to organize healthcare workforce during pandemics: application to COVID-19
Sanchez-Taltavull, D., Candinas, D., Roldan, E., Beldi, G.
10.1101/2020.03.23.20041863 — Posted: 2020-03-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).